Security key
22978P106
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 13,849,849
- Total 13F value
- $50,545,862
- Share change
- +1,799,013
- Put/Call ratio
- 49%
- SEC-reported price per share
- $3.65
- Number of holders
- 77
- Value change
- +$6,687,288
- Number of buys
- 51
- Number of sells
- 22
- Shares outstanding
- 43,411,663
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
77
Top holders
10
CUE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Cue Biopharma, Inc. SEC filings
Cue Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22978P106
Recent filing periods:
Ownership snapshot
Top reported holders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Mark E. Strome
Disclosed value leader
Slate Path Capital LP
Comparable rows
15/15
Latest evidence
31 Mar 2023
13D/G
13F
Lead comparable stake: 5%
13D/G row: Mark E. Strome
Showing 1-6 of 15 holder rows.
Quick read
Mark E. Strome leads the comparable SEC ownership view at 5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Mark E. Strome's linked filing trail.
Comparable ownership
Top 5
Mark E. Strome
5%
Slate Path Capital LP
5.5%
VANGUARD GROUP INC
3.8%
Prosight Management, LP
2.7%
Bleichroeder LP
1.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Mark E. Strome |
13D/G
|
5%
|
$1,862,968
2,166,242 shares
|
$0 | 14 Nov 2022 |
| Slate Path Capital LP |
13F
Company
|
5.5%
|
$8,576,764
2,402,455 shares
|
— | 31 Mar 2023 |
| VANGUARD GROUP INC |
13F
Company
|
3.8%
|
$5,903,338
1,653,596 shares
|
— | 31 Mar 2023 |
| Prosight Management, LP |
13F
Company
|
2.7%
|
$4,112,122
1,151,855 shares
|
— | 31 Mar 2023 |
| Bleichroeder LP |
13F
Company
|
1.7%
|
$2,695,450
755,028 shares
|
— | 31 Mar 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
1.5%
|
$2,372,000
664,426 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
77
Shares
13,849,849
Rows available
77
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
62
Q2 2023 holders
77
Holder diff
15
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend